Indoco Remedies has informed that further to the notification dated October 11, 2024, for receipt of Official Action Indicated (OAI) status from the USFDA for Plant II & Plant III facility located at Goa (Facility), subsequently the Facility has received a warning letter from USFDA on December 17, 2024. This Facility was inspected from July 16, 2024 to July 26, 2024.
The above information is a part of company’s filings submitted to BSE.